J Acquir Immune Defic Syndr

• 

  Publication Venue For

  • Trajectories of Depressive Symptoms, Neurocognitive Function, and Viral Suppression With Antiretroviral Therapy Among Youth With HIV Over 36 months..  87:851-859. 2021
  • Brief Report: Prediction of Serum HIV-1 Neutralization Titers After Passive Administration of VRC01..  83:434-439. 2020
  • Crowdsourcing Methods to Enhance HIV and Sexual Health Services: A Scoping Review and Qualitative Synthesis..  82 Suppl 3:S271-S278. 2019
  • Hypertension Control and Retention in Care Among HIV-Infected Patients: The Effects of Co-located HIV and Chronic Noncommunicable Disease Care..  82:399-406. 2019
  • Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART..  81:e6-e9. 2019
  • Prediction of HIV Transmission Cluster Growth With Statewide Surveillance Data..  80:152-159. 2019
  • Leveraging Phylogenetics to Understand HIV Transmission and Partner Notification Networks..  78:367-375. 2018
  • Brief Report: Frequency of Monitoring Kidney Function in HIV-Uninfected Persons Using Daily Oral Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis..  77:206-211. 2018
  • Partnerships Between a University-Affiliated Clinic and Community-Based Organizations to Reach Black Men Who Have Sex With Men for PrEP Care..  77:e25-e27. 2018
  • HIV Preexposure Prophylaxis Implementation at Local Health Departments: A Statewide Assessment of Activities and Barriers..  77:72-77. 2018
  • The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine Care..  76:402-408. 2017
  • Social Network Clustering and the Spread of HIV/AIDS Among Persons Who Inject Drugs in 2 Cities in the Philippines..  76:26-32. 2017
  • The Impact of Couple HIV Testing and Counseling on Consistent Condom Use Among Pregnant Women and Their Male Partners: An Observational Study..  75:417-425. 2017
  • Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay..  75:241-245. 2017
  • PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi..  74:367-374. 2017
  • Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease..  73:403-410. 2016
  • Complications and Route of Delivery in a Large Cohort Study of HIV-1-Infected Women-IMPAACT P1025..  73:74-82. 2016
  • Plasma and Intracellular Concentrations in HIV-Infected Patients Requiring Hemodialysis Dosed With Tenofovir Disoproxil Fumarate and Emtricitabine..  73:e8-e10. 2016
  • Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021..  72:372-375. 2016
  • Characteristics of Age-Discordant Partnerships Associated With HIV Risk Among Young South African Women (HPTN 068)..  72:423-429. 2016
  • High-Frequency Illegitimate Strand Transfers of Nascent DNA Fragments During Reverse Transcription Result in Defective Retrovirus Genomes..  72:353-362. 2016
  • Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials..  71:e115-e118. 2016
  • Participants' Explanations for Nonadherence in the FEM-PrEP Clinical Trial..  71:452-461. 2016
  • Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis..  71:374-380. 2016
  • Incorporating Acute HIV Screening into Routine HIV Testing at Sexually Transmitted Infection Clinics, and HIV Testing and Counseling Centers in Lilongwe, Malawi..  71:272-280. 2016
  • Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women..  71:137-145. 2016
  • HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds..  70:42-53. 2015
  • Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China..  69:403-412. 2015
  • Outcomes Up to 12 Months After Treatment With Loop Electrosurgical Excision Procedure for Cervical Intraepithelial Neoplasia Among HIV-Infected Women..  69:200-205. 2015
  • Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061..  69:52-60. 2015
  • The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills..  68:578-584. 2015
  • Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls..  68:264-273. 2015
  • Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP..  67:555-563. 2014
  • Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine..  67:36-44. 2014
  • HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research..  67 Suppl 1:S40-S53. 2014
  • FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis..  66:324-331. 2014
  • Factors associated with recurrence of cervical intraepithelial neoplasia 2+ after treatment among HIV-infected women in Western Kenya..  66:188-192. 2014
  • World Health Organization's stage 4 conditions among adults accessing outpatient HIV care: a retrospective cohort study in Kisumu, Kenya..  65:e152-e155. 2014
  • Postpartum depression and HIV infection among women in Malawi..  65:359-365. 2014
  • Reduced adherence to antiretroviral therapy among HIV-infected Tanzanians seeking cure from the Loliondo healer..  65:e104-e109. 2014
  • Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease..  64:382-391. 2013
  • Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy..  64:374-381. 2013
  • Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation..  62:505-508. 2013
  • Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa..  62:e55-e57. 2013
  • Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals..  61:302-309. 2012
  • Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study..  60:393-399. 2012
  • Childhood trauma and health outcomes in HIV-infected patients: an exploration of causal pathways..  59:409-416. 2012
  • HIV/HCV-coinfected natural viral suppressors have better virologic responses to PEG-IFN and ribavirin than ARV-treated HIV/HCV patients..  58:e38-e40. 2011
  • Mental health and HIV sexual risk behavior among patrons of alcohol serving venues in Cape Town, South Africa..  57:230-237. 2011
  • Factors associated with decreased kidney function in HIV-infected adults enrolled in the MTCT-Plus Initiative in sub-Saharan Africa..  57:40-45. 2011
  • A cost-effectiveness analysis of alternative HIV retesting strategies in sub-saharan Africa..  56:443-452. 2011
  • Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire..  56:356-364. 2011
  • Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens..  56:325-332. 2011
  • Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy..  56:83-90. 2011
  • Acute Dengue fever causes false-positive reactivity in OraQuick rapid HIV-1/2 antibody test..  55:641. 2010
  • HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study..  55:65-72. 2010
  • Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection..  55:73-77. 2010
  • Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study..  54:368-375. 2010
  • Results of the NIMH collaborative HIV/sexually transmitted disease prevention trial of a community popular opinion leader intervention..  54:204-214. 2010
  • Hepatitis C and the risk of kidney disease and mortality in veterans with HIV..  53:222-226. 2010
  • Characteristics of HIV voluntary counseling and testing clients before and during care and treatment scale-up in Moshi, Tanzania..  52:648-654. 2009
  • Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia After Prison Release: The imPACT Trial. 2017
  • Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care. 2016